CBD or CBN: what are the chemical and legal differences?

CBD is produced by the plant from CBGA (the "mother cannabinoid"), via the enzyme CBDA synthase, then decarboxylated into CBD under the effect of heat. It has been authorised for sale since the Conseil d'État ruling of 29 December 2022, subject to an authorised variety and finished THC ≤ 0.30 %. Non-intoxicating, it does not produce the "high" of recreational cannabis. No health claim has been approved by EFSA, which published in February 2026 a provisional safe daily dose of around 2 mg per day for a 70 kg adult - well below the usual 15 to 50 mg in a commercial oil dose.

CBN was the first phytocannabinoid to be isolated, in the late nineteenth century. Unlike CBD, it does not come directly from hemp's biosynthetic pathway: it results from the oxidative degradation of THC, under the effect of light, heat and oxygen. A fresh flower contains very little of it; an aged flower or an extract exposed to air gradually accumulates it. Like CBD, CBN may be sold as long as the finished product respects the 0.30 % THC threshold, and it is not classified as a narcotic. Clinical studies on its effects remain few in number and low in power; no health claim is permitted in Europe.

This marketing association is a recent one and rests on preliminary studies, including a notable American trial run on several hundred participants. Those data remain insufficient to support a health claim. In France, the HAS recommends a three-step strategy for insomnia: sleep hygiene, cognitive behavioural therapy, then medication as a last resort. CBN features in none of those steps. For a full picture of the research on this subject, see our guide to CBN and sleep.

CBD and CBN both interact with the endocannabinoid system, a network of CB1 receptors (mostly in the brain) and CB2 receptors (mostly in the immune system). CBD has a low affinity for these receptors and acts mainly through indirect modulation. CBN has a more marked affinity for CB1, which could explain its slight psychoactive effect at high doses. These mechanisms are documented in vitro; how far they translate into clinical effects in humans remains only partly established.

Several oils on the French market combine CBD and CBN in varying ratios, generally from 3:1 to 10:1 in favour of CBD, on the hypothesis of the "entourage effect" - a synergy between cannabinoids that is still under scientific investigation. No controlled clinical study supports the value of any specific combination. If you try this type of product, insist on the certificate of analysis from an independent laboratory, confirming the stated levels and the absence of prohibited cannabinoids (HHC, H4CBD, THCP, classified as narcotics since 2023-2024).

Is CBN stronger than CBD?

"Stronger" means nothing outside a defined clinical framework. CBN has a more marked affinity for the CB1 receptor, which would explain a slight psychoactive effect at very high doses that CBD does not have. No study compares their "potency" against a given health endpoint.

Can you drive after taking CBN?

CBN itself is not looked for by saliva tests. A full-spectrum product containing CBN may, however, contain traces of THC that would make a test positive. Choose a certified THC-free isolate.

Is CBN banned in France?

No, it may be sold just as CBD may, provided the finished product respects the 0.30 % THC threshold. It is not on the list of narcotics.

CBD or CBN for an evening ritual?

Both can be part of an evening ritual with no therapeutic pretension. If your sleep problems go beyond three weeks, see a doctor: cognitive behavioural therapy remains the reference treatment approved by the HAS.